Stay updated on Pembrolizumab for Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedThe revision label was updated from v3.6.2 to v3.6.3, signaling a newer version of the study protocol/document referenced on the page.SummaryDifference0.1%

- Check14 days agoChange DetectedThe document revision was updated from v3.6.0 to v3.6.2, signaling a newer version of the trial-related documentation linked on the page. This reflects an update to the document's version rather than changes to the page's core content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study page now indicates that recruitment has ended, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to guide users in understanding and interacting with the study record.SummaryDifference0.4%

- Check35 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer version of the page's documentation. No study content, data, or functionality were changed.SummaryDifference0.1%

- Check57 days agoChange DetectedNew revision entries were added to the page’s revision history (v3.5.4 with recent dates). The older revision (v3.5.3) and its dated entries were removed.SummaryDifference0.3%

- Check78 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a site release/version change without modifying the study details presented.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.